
Ayush Agrawal Research has a primary focus on SMID space. We aim to provide an independent perspective on SMID companies. You can check out our model portfolio offerings by clicking here.
Research Philosophy at Ayush Agrawal Research
Through our research desk, we primarily try to analyze under-researched companies based promotor vision which are at a nascent stage, young in market capitalization, and not too expensive in valuations.
We focus more on the qualitative rather than the quantitative aspect of research. However, we also see:
Earnings Momentum
Keeping a close eye on financial performance is key. We celebrate exceptional results and swiftly adapt to unexpected shifts, ensuring we're on the pulse of companies making strides.
Recent Updates
Staying updated is crucial. We track victories like securing large contracts, strategic moves in mergers and acquisitions, new product launches, joint ventures, buybacks, market entries, and government initiatives.
Sector Rotation
Understanding market cycles is our forte. We pick the right sectors at the right time, leveraging our unique system for strategic investments that align with sector trends, offering safety margins and outperformance.
Technical Strength
Decisions guided by technical indicators set us apart. From identifying potential with SMA150 crossovers to prioritizing high relative strength, recognizing opportunities with RSI, leveraging strength with ADX, and spotting potential in base breakouts—we're thorough.
Demand & Supply
Navigating market entry is an art. We pinpoint smart investor opportunities, react to promoter buying signals, stay tuned to FII/DII trends, and strategically handle preferential allotments, ensuring a strategic and informed market presence.
SAMPLE REPORTS
FAQs
Ayush Agrawal Research has a primary focus on SMID space. We aim to provide an independent perspective on SMID companies.
Through my research desk, I will primarily try to do analysis based on companies with a promotor vision, under-researched, at a nascent stage, young in market capitalisation, and very affordable in valuations. I will also look for arbitrage opportunities based on specific patterns and special situations I have observed.
We have a Quant Strategy based model portfolio hosted on smallcase and a research report service called SwingX where reports are shared via Zoho WorkDrive.
The SwingX reports are shared via Zoho WorkDrive. The model portfolio service is offered via smallcase.
We are currently not taking new clients or renewals for HNI Research.
SwingX Quarterly Charges are 5296/- + GST
smallcase Quarterly Charges are 7415/- + GST
I have established internal guidelines and policies designed to mitigate any potential conflicts of interest.
No free trials are offered as the recommendations are given under public appearance guidelines.
For the same, please read the Cancellation Policy
If we in future take any subscriptions, we will give refund when clients ask.
This is happening due to your membership ending with us on our previously offered paid plans.
1. About Research Analyst:
Ayush Agrawal (hereinafter referred to as the Research Analyst) is registered with SEBI as a Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide Registration number INH000013013 on September 14, 2023, having its office at First Floor, B.P. Complex, Jeevan Colony, Baldeo bag, Jabalpur, Dist- Jabalpur.
Pursuant to which he provides research analysis services to his clients.
2. About the Individual:
Ayush Agrawal holds a degree in Post Graduate Programme in Family Managed Business and Finance Modelling & Valuation Analyst (FMVA). He has been actively involved in the security market, gaining valuable experience and knowledge in investment strategies and analysis. He has a strong analytical skill to identify investment ideas.
3. Details of Business activities:
The Research Analyst shall provide research services on low P/E companies which have promotor vision, are under researched, at a nascent stage, young in market capitalisation, and are very affordable in valuations. Apart from this, recommendations will be provided on potential arbitrage opportunities. The Research Analyst shall also be giving out recommendations on which ETFs are to be purchased to diversify portfolio to mitigate risk.
The Research Analyst will keep strict stop loss levels for all the recommendations that are given. Whenever a scenario occurs where the arbitrage does not play out and stop loss levels are breached, EXIT calls will be given.
4. Disciplinary History:
There are no outstanding litigations or no disciplinary history in my name.
5. Terms and Conditions on which Research Report is being issued:
The Research Analyst has exercised due diligence in checking the correctness and authenticity of the information contained herein, so far as it relates to current and historical information, but does not guarantee its accuracy or completeness. The opinions expressed are based on our current research as of the date appearing in the material and may be subject to change from time to time without notice.
The Research Analyst does not accept any liability arising from the use of this document or the information contained herein. The recipients of this material should rely on their own judgment and take their own professional advice before acting on this information.
The Research Analyst shall not be in any way responsible for any loss or damage that may arise to any person/s from any inadvertent error in the information contained, views and opinions expressed in this publication.
6. The Research Analyst, including relatives-
· do not hold any financial interest in the Company.
· do not have any actual/beneficial ownership of more than 1% in the company.
· do not have any other material conflict of interest.
7. The Research Analyst or its associates are not affiliated with any other intermediaries or have received any brokerage or commission from any third party.
8. The Research Analyst or its associates have not received any compensation from the Company covered by Research Analyst during the past twelve months.
9. The Research Analyst or its associates have not managed or co-managed public offering of securities of the Company during the past twelve months.
10 The Research Analyst has not served as an officer, director or employee of the Company and has not been engaged in the market making activity of the Company.
11. The Research Analyst have ensured that the facts mentioned in the research report are taken from the reliable source and information. However, the investors are advised to independently evaluate the market conditions/ risks involved before making the investment decision.
Please Click Here to refer to same.
Please drop a mail to themicrocapinvestor@gmail.com with FAQ as Subject Line asking your query. I will get back within 24-48 hours.
Data for the Month Ending September 2025 | |||||||
---|---|---|---|---|---|---|---|
Sr. No. | Received from | Pending at the end of last month | Received | Resolved | Total Pending | Pending complaints > 3months | Average Resolution time (in days) |
1 | Directly from Investors | 0 | 0 | 0 | 0 | 0 | - |
2 | SEBI (SCORES) | 1 | 0 | 1 | 0 | 0 | - |
3 | Other Sources | 0 | 0 | 0 | 0 | 0 | - |
Grand Total | 0 | 0 | 0 | 0 | 0 | - | |
Trend of Monthly Complaints | |||||||
Sr. No. | Month | Carried forward from previous month | Received | Resolved | Pending | ||
1 | October 2024 | 0 | 0 | 0 | 0 | ||
2 | November 2024 | 0 | 0 | 0 | 0 | ||
3 | December 2024 | 0 | 0 | 0 | 0 | ||
4 | January 2025 | 0 | 0 | 0 | 0 | ||
5 | February 2025 | 0 | 0 | 0 | 0 | ||
6 | March 2025 | 0 | 0 | 0 | 0 | ||
7 | April 2025 | 0 | 1 | 0 | 0 | ||
8 | May 2025 | 0 | 0 | 1 | 0 | ||
9 | June 2025 | 0 | 0 | 0 | 0 | ||
10 | July 2025 | 0 | 0 | 0 | 0 | ||
11 | August 2025 | 0 | 0 | 0 | 0 | ||
12 | September 2025 | 0 | 0 | 0 | 0 | ||
Trend of Annual Complaints | |||||||
Sr. No. | Year | Carried forward from previous year | Received | Resolved | Pending | ||
1 | 2023-24 | 0 | 0 | 0 | 0 | ||
2 | 2024-25 | 0 | 1 | 0 | 1 | ||
3 | 2025-26 | 1 | 0 | 1 | 0 |
Sr. No. | FinancialYear | Compliance audit status | Remarks, If any | ||||
---|---|---|---|---|---|---|---|
1 | 2023-24 | Conducted | No adverse remarks from auditor | ||||
2 | 2024-25 | Conducted | No adverse remarks from auditor |